|
Associate Professor Barry Powell and his colleagues in the
Craniofacial Unit were awarded NHMRC funding for research
into the mechanisms of craniosynostosis.
A/Prof Maria Makrides and Prof Robert Gibson were awarded
NHMRC funding to conduct the 7-year follow-up of preterm
infants enrolled in an earlier trial.
Dr Guy Sander was awarded NHMRC funding for research into
the mechanisms of coeliac disease.
Prof Robert Gibson had his NHMRC Senior Research
Fellowship renewed and was awarded an ARC grant to extend
his work in fatty acid metabolism.
Alison Clarke, Subhobrata Das and Lucy Simmonds were
awarded 1st Class Honours.
The CRC for Diagnostics wound up, having seeded the new
CRC for Biomarker Translation. During its lifetime the CRC
spun out Evogenix, which floated and has since merged with
Peptech to form Arana Ltd, and more recently AdAlta Pty Ltd.
IP created by the Leukocyte Biology lab jointly with La Trobe
University was independently valued at $3 million and was
made available to the new CRC. In addition, WCHRI received
cash and shares worth over $400,000.
A/Prof Richard D’Andrea’s Leukaemia Laboratory were
awarded NHMRC funding for a project entitled “Molecular
Genetics of Polycythemia vera” Richard’s group have
relocated
to the Hanson Institute but will maintain an active
involvement at WCHRI.
Dr Imme Penttila was awarded an NHMRC project grant jointly
with Adrian Cummins at the QEH. The grant is to work on
assessing regulation of intestinal stem cells and intestinal
growth.
Dr Debbie Palmer was awarded an NHMRC postdoctoral
award to support her work in nutritional strategies to
reduce allergies.
The work of the CNRC was influential in achieving a change
in the national and international food law that governs the
composition of infant formulas.
In 2007 Dr Penttila was invited as a keynote speaker to present
at the International Workshop in Utrecht: Dairy and Gut Health”
May 2007 “Transforming Growth factor Beta and inducing
oral
tolerance”. Only one researcher from each country is
chosen to
show case their research at this bi-annual forum.
A/Prof Allison Cowin’s studies on wound healing, selected
for the NHMRC’s “10 of the best” publications
for 2008, has
moved towards commercialisation of antibody mediated
therapy, with support from Bio Innovation SA. Allison has
been awarded an NHMRC Career Development Award and
a Development Grant from the same funding body.
|
